3,010
Participants
Start Date
June 30, 2001
Primary Completion Date
June 30, 2009
Study Completion Date
December 31, 2009
Trastuzumab
8 mg/kg at month M6, followed by a maintenance dose of 6 mg/kg every 3 weeks for a 1 year (i.e. 18 injections in total)
Cyclophosphamide
500 mg/m², D1 and every 3 weeks
docetaxel
on day D1 of each cycle : dose: 75 mg/m², route: i.v. injection over 1 hour, every 3 weeks
Epirubicin
100 mg/m², D1 and every 3 weeks
Fluorouracil
500 mg/m², D1 and every 3 weeks
Institut J. Paoli and I. Calmettes, Marseille
Centre Regional Francois Baclesse, Caen
Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon
Centre Hospitalier General Andre Boulloche, Montbéliard
Institut Claudius Regaud, Toulouse
Institut Bergonie, Bordeaux
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier
Centre Eugene Marquis, Rennes
Institut Prive de Cancerologie, Grenoble
Centre Regional Rene Gauducheau, Nantes-Saint Herblain
Centre Paul Papin, Angers
Institut Jean Godinot, Reims
Centre Hospitalier Regional Metz Thionville, Metz
Centre Jean Perrin, Clermont-Ferrand
Centre Paul Strauss, Strasbourg
Hopitaux Universitaire de Strasbourg, Strasbourg
Centre Hospitalier de Mulhouse, Mulhouse
Hopital Avicenne, Paris
CMC Les Ormeaux, Le Havre
Clinique du Petit Colmouilins, Harfleur
Centre Hospitalier de Lagny, Lagny-sur-Marne
Hopital Andre Mignot, Le Chesnay
CHU Poitiers, Poitiers
Hopital Intercommunal De Creteil, Créteil
Clinique Sainte Clotilde, Sainte Clotilde
Centre Hospitalier d'Annecy, Annecy
C.H. Bourg En Bresse, Bourg-en-Bresse
Clinique Saint - Pierre, Perpignan
Institut Gustave Roussy, Villejuif
UNICANCER
OTHER